Monthly Archives: October 2015

The legal reality: doctors cannot prescribe research peptides

Lorem ipsum dolor sit amet, consectetur adipiscing elit. In sed vulputate massa. Fusce ante magna, iaculis ut purus ut, facilisis ultrices nibh. Quisque commodo nunc eget tortor dapibus, et tristique magna convallis. Phasellus egestas nunc eu venenatis vehicula. Phasellus et magna nulla. Proin ante nunc, mollis a lectus ac, volutpat placerat ante. Vestibulum sit amet […]

Legal risks for patients buying research peptides

Patients face a different set of risks. The legal exposure is generally lower than for physicians, but health risks may be higher. Personal use enforcement The good news for individuals is that the FDA primarily focuses enforcement on sellers, not buyers. Personal possession of research peptides for self-administration rarely results in criminal prosecution. However, “rarely” […]